Pediatric therapeutic monitoring faces several challenges, including difficulties in blood sample collection due to smaller blood volumes and ethical considerations. Moreover, there is a lack of comprehensive pharmacokinetic data in children, necessitating extrapolation from adult data. This can lead to inaccuracies in dosing if not carefully managed.
